Skip to main content
. 2018 Jan 31;33(4):415–423. doi: 10.1007/s10654-018-0360-5

Table 3.

OR with 95% CI of developing ACPA positive RA and ACPA negative RA for smokers compared with never-smokers, by duration (years) and intensity of smoking (number of cigarettes smoked daily)

ACPA positive RA
Intensity
Duration
0 < 10 10–20 > 20
0 730/2655 1.0 (reference)
0–10 77/268 1.0 (0.8–1.2) 78/262 1.4 (1.2–1.8) 264/257 1.6 (1.3–2.1)
11–19 68/222 1.2 (0.9–1.7) 126/311 1.6 (1.2–2.2) 555/777 1.7 (1.2–2.4)
20– 34/109 2.8 (2.3–3.4) 74/188 2.9 (2.5–3.4) 325/476 2.8 (2.3–3.3)
ACPA negative RA
Intensity
Duration
0 < 10 10–20 > 20
0 480/2655 1.0 (reference)
0–10 52/268 1.1 (0.8–1.5) 57/262 1.0 (0.7–1.2) 128/457 0.9 (0.6–1.2)
11–19 34/222 1.3 (0.9–1.9) 76/311 1.3 (0.9–1.9) 200/777 1.3 (0.8–2.0)
20– 12/109 1.6 (1.3–2.1) 128/188 1.6 (1.3–2.0) 134/476 1.6 (1.2–2.0)

Adjusted for age, gender, residential area, study, ancestry, educational level, passive smoking, alcohol consumption, and body mass index at inclusion in the study